Recent Updates
Recently added Catalysts
LNTH Negative Sentiment Score: 30/100

LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Lantheus Holdings, Inc. Investors of Upcoming Deadline

Key Takeaway: Bernstein Liebhard LLP has issued a reminder to investors of Lantheus Holdings, Inc. regarding a deadline related to a securities fraud class action lawsuit. The lawsuit alleges that the company made misrepresentations about its oncology product, Pylarify, which may have affected its competitive position. Investors who purchased shares between February 26 and August 5, 2025, are encouraged to assess their legal rights and options. A lead plaintiff is sought for the class action, and shareholders are urged to act by November 10, 2025, should they wish to participate.

Market Sentiment Analysis

CONCERNS & RISKS

  • Shareholder class action lawsuit indicates potential legal troubles.
  • Allegations of misrepresentation regarding key product Pylarify.
  • Deadline for lead plaintiff submission may cause stress to investors.
  • Investors might have incurred losses during the relevant period.

Full Press Release Details

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
Should You Join This Class Action Lawsuit?
Do you, or did you, own shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)?
Did you purchase your shares between February 26, 2025 and August 5, 2025, inclusive?
Did you lose money in your investment in Lantheus Holdings, Inc.?
If you purchased or acquired Lantheus securities, and/or would like to discuss your legal rights and options please visit Lantheus Holdings, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
A lawsuit was filed in the United States District Court for the Southern District of New York on behalf of investors who purchased or acquired the securities of Lantheus between February 26, 2025 and August 5, 2025, inclusive.
According to the lawsuit, Defendants made misrepresentations concerning the competitive position of the Company’s key Radiopharmaceutical Oncology product, Pylarify.
If you wish to serve as lead plaintiff for the Class, you must file papers by November 10, 2025. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.
ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Investor Relations Manager
Bernstein Liebhard LLP

Tags

lantheus class action

Frequently Asked Questions

What is the deadline for joining the Lantheus class action?

The deadline to file as a lead plaintiff is November 10, 2025.

Who can join the Lantheus Holdings class action lawsuit?

Investors who purchased Lantheus shares between February 26, 2025, and August 5, 2025.

What should I do if I lost money in Lantheus investments?

You may contact Investor Relations or visit the class action lawsuit page.

Is there a fee to participate in this class action?

No, all representation is on a contingency fee basis with no upfront costs.

What did the lawsuit allege against Lantheus?

The lawsuit claimed misrepresentations regarding the competitive position of Pylarify.

Last updated: Nov 3, 2025